首页> 外文期刊>Indian heart journal >Primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Outcomes and determinants of outcomes: A tertiary care center study from North India
【24h】

Primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Outcomes and determinants of outcomes: A tertiary care center study from North India

机译:急性ST段抬高型心肌梗死的主要经皮冠状动脉介入治疗:结果和结果决定因素:北印度的一家三级医疗中心研究

获取原文
           

摘要

Background: Primary percutaneous coronary intervention (PCI) is the current standard of care for acute ST elevation myocardial infarction (STEMI). Most of the data on primary PCI in acute STEMI is from western countries. We studied the outcomes of primary PCI for acute STEMI at a tertiary care center in North India. Methods: Consecutive patients undergoing primary PCI for STEMI were prospectively studied during the period from February 2103 to May 2015. The outcomes assessed were all cause in hospital mortality, factors associated with mortality, major adverse cardiac and cerebrovascular event rate (composite of all cause in hospital mortality, non-fatal re infarction and stroke) and procedural complications. Results: 371 patients underwent primary PCI during the study period. The mean age was 54 years and 82.7% were males. The mean total ischemia time and door to balloon times were 6.8h and 51min respectively. 96.4% patients underwent successful primary PCI. The total in hospital mortality was 12.9%. Mortality with cardiogenic shock at presentation was 66.7% while non-shock mortality was 2.6%. In hospital MACCE rate was 13.5%. Factors significantly associated with mortality were KILLIP class (OR: 8.4), door to balloon time (OR 1.02), final TIMI flow (OR 0.44) and severe LV dysfunction (OR 22.0). Procedure related adverse events were rare and there was no non-CABG associated major TIMI bleeding. Conclusion: Primary PCI for acute STEMI is feasible in our setup and associated with high success rate, low mortality in non-shock patients and low complication rates.
机译:背景:主要的经皮冠状动脉介入治疗(PCI)是急性ST段抬高型心肌梗塞(STEMI)的当前护理标准。急性STEMI中主要PCI的大多数数据来自西方国家。我们在印度北部的一家三级医疗中心研究了急性PCI治疗急性STEMI的主要PCI结果。方法:前瞻性研究2103年2月至2015年5月期间接受原发性PCI治疗的连续性患者。评估的结局全部为医院病因,死亡率相关因素,严重心脏和脑血管不良事件发生率(医院死亡率,非致命性再梗塞和中风)和手术并发症。结果:在研究期间有371例患者接受了原发性PCI。平均年龄为54岁,男性为82.7%。平均总缺血时间和门至球囊时间分别为6.8h和51min。 96.4%的患者接受了成功的原发性PCI。医院总死亡率为12.9%。表现为心源性休克的死亡率为66.7%,而非休克死亡率为2.6%。在医院,MACCE率为13.5%。与死亡率显着相关的因素包括KILLIP级(OR:8.4),开气球时间(OR 1.02),最终TIMI流量(OR 0.44)和严重的LV功能障碍(OR 22.0)。与手术相关的不良事件很少见,并且没有非CABG相关的TIMI大出血。结论:急性STEMI的主要PCI在我们的设置中是可行的,并具有较高的成功率,非休克患者的低死亡率和低并发症发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号